Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-25-034662

Chief Accounting Officer sold 571 shares at $6.29 ($3,592)

From the SEC's structured data for this filing

Trades in this filing

Abate Kristin · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Sale : show line 1 in the form −571 $6.29 $3,592 9,713 D
Open-market sales · 571 sh · avg $6.29 · $3,592
Loading xslF345X05/ownership.xml…